CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis
Chemotherapy-free treatment of VAF induces early and deep molecular response in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a prospective, single-center, single-arm, phase 2 trial
OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway
NAC1 Promotes Stemness and Regulates Myeloid-derived Cell Status in Triple-Negative Breast Cancer
Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early stage NSCLC.
The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma
LINC01852 inhibits tumorigenesis and chemoresistance in colorectal cancer by regulating SRSF5-mediated PKM alternative splicing
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD- 1/PD-L1 axis blockade via Id1 downregulation
EYA4 drives breast cancer progression and metastasis through its novel role in replication stress avoidance.
Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors